During the development process of SS, IFN-γ contributes to the activation of Th1 cells, the upregulation of MHC Class II of antigen-presenting or epithelial cells, the production of IFN-γ-inducible proteins, and the activation of various immune cells expressing IFN-γ receptor (37). The gene discussed is IFNG; the disease is synovial sarcoma.